novel
coronaviru
name
ictv
coronavirida
studi
group
februari
caus
sever
respiratori
spread
around
world
februari
confirm
case
death
rais
urgent
need
effect
treatment
deadli
diseas
howev
current
antivir
drug
limit
effect
although
gilead
nuc
nucleosid
inhibitor
previous
fail
treat
ebola
seem
benefit
patient
washington
usa
remain
unknown
whether
drug
effect
viru
patient
may
infect
differ
variant
viru
analysi
rna
genom
patient
china
usa
australia
reveal
virus
differ
sequenc
fig
differ
mostli
singl
nucleotid
variat
fig
show
exampl
singl
nucleotid
variat
result
chang
amino
acid
polypeptid
implic
drive
coronaviru
transit
bat
evid
patient
sampl
suggest
activ
acquir
new
mutat
may
enabl
escap
antivir
drug
rais
seriou
challeng
develop
convent
drug
vaccin
limit
appli
deadli
rna
virus
sar
mer
group
implement
flexibl
effici
approach
target
rna
laboratori
use
technolog
review
propos
system
use
specif
chew
rna
genom
henc
limit
abil
reproduc
function
disrupt
viru
specif
use
guid
rna
grna
concomitantli
target
repres
replicasetranscriptas
spike
viru
gilead
nuc
inhibitor
remdesivir
similar
chemic
structur
hiv
reversetranscriptas
inhibitor
current
test
clinic
trial
drug
target
spike
glycoprotein
also
test
phase
trial
treatment
hiv
rnaguid
rnatarget
crispr
cleav
rna
genom
protein
guid
rnascontain
spacer
sequenc
specif
complementari
viru
rna
genom
use
fig
one
advantag
system
flexibl
respect
design
guid
rna
rnatarget
cleavag
activ
depend
presenc
specif
adjac
sequenc
ngg
motif
dnaedit
effector
uniqu
featur
system
meet
requir
rapid
develop
guid
rna
target
differ
viru
variant
evolv
may
escap
tradit
drug
total
design
guid
rna
specif
target
peptidecod
region
viru
rna
genom
without
affect
human
transcriptom
fig
due
desir
safeti
profil
adenoassoci
viru
aav
serv
vehicl
deliv
effector
patient
infect
small
size
effector
make
suitabl
allinon
aav
deliveri
guiderna
array
fig
three
guid
rna
target
differ
peptideencod
region
rna
genom
packag
one
aav
vector
fig
make
system
effici
viru
clearanc
resist
prevent
express
driven
tissuespecif
promot
achiev
precis
treatment
infect
organ
addit
aav
serotyp
highli
specif
lung
main
organ
infect
thu
exploit
target
deliveri
crispr
system
similar
strategi
applic
type
rna
virus
taken
togeth
propos
system
potenti
straightforward
flexibl
rapid
novel
approach
treatment
prevent
rna
viru
infect
futur
studi
determin
safeti
efficaci
system
elimin
virus
anim
model
need
therapeut
applic
patient
proven
effect
therapeut
approach
provid
patient
worldwid
option
fight
lifethreaten
virus
potenti
evolv
develop
resist
rapidli
